Trial record 1 of 1 for:
GCT1053-01
A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05435339 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 28, 2022
Last Update Posted : May 7, 2024
|
Sponsor:
Genmab
Collaborator:
BioNTech SE
Information provided by (Responsible Party):
Genmab
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | September 1, 2026 |
| Estimated Study Completion Date : | December 1, 2026 |